Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) EBIT (2016 - 2025)

Historic EBIT for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to -$56.4 million.

  • Wave Life Sciences' EBIT rose 1183.13% to -$56.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$135.9 million, marking a year-over-year increase of 1059.05%. This contributed to the annual value of -$110.4 million for FY2024, which is 6236.69% down from last year.
  • Latest data reveals that Wave Life Sciences reported EBIT of -$56.4 million as of Q3 2025, which was up 1183.13% from -$52.8 million recorded in Q2 2025.
  • Wave Life Sciences' EBIT's 5-year high stood at $23.0 million during Q4 2024, with a 5-year trough of -$63.9 million in Q3 2024.
  • Over the past 5 years, Wave Life Sciences' median EBIT value was -$38.1 million (recorded in 2022), while the average stood at -$33.0 million.
  • The largest annual percentage gain for Wave Life Sciences' EBIT in the last 5 years was 22293.65% (2024), contrasted with its biggest fall of 153823.13% (2024).
  • Over the past 5 years, Wave Life Sciences' EBIT (Quarter) stood at -$36.1 million in 2021, then fell by 20.64% to -$43.6 million in 2022, then skyrocketed by 57.11% to -$18.7 million in 2023, then soared by 222.94% to $23.0 million in 2024, then plummeted by 345.37% to -$56.4 million in 2025.
  • Its last three reported values are -$56.4 million in Q3 2025, -$52.8 million for Q2 2025, and -$49.8 million during Q1 2025.